LG SIGNATURE LSR100 Manual Del Usuario página 216

Quantité
Réduction de moyenne
Contaminants d'eau à
traiter
100,000
Cyst*
cysts/L
Aténolol 240 ng/L
Carbamazépine 1600 ng/L
DEET 1600 ng/L
Triméthoprime 170 ng/L
Linuron 160 ng/L
Phénytoïne 200 ng/L
Ibuprofène 400 ng/L
Naproxène 140 ng/L
Estrone 120 ng/L
Bisphénol A 2000 ng/L
Nonyl Phénol 1600 ng/L
• Basé sur l'utilisation des Oocytes de Cryptosporidium Parvum.
48
Concentration Réduction
de Moyenne
Provocation %
Minimum
>99,99%
50,000 cysts/L
200 ± 40% ng/L > 95.50%
1400 ± 40%
0.984
ng/L
1400 ± 40%
0.971
ng/L
140 ± 40% ng/L >96,80%
140 ± 40% ng/L >96.60%
200 ± 40% ng/L >94,80%
400 ± 40% ng/L >94,50%
140 ± 40% ng/L >96,10%
140 ± 40% ng/L >96,10%
2000 ± 40%
>98,90%
ng/L
1400 ± 40%
>97,10%
ng/L
Concentration
Concentration
Maximale
Moyenne
Admissible
en Eau du
en Eau du
Produit
Produit
10 N/A
10,80 ng/L 30 ng/L
25,60 ng/L 200 ng/L
46,40 ng/L 200 ng/L
5,44 ng/L 20 ng/L
5,44 ng/L 20 ng/L
10,40 ng/L 30 ng/L
22,00 ng/L 60 ng/L
5,46 ng/L 20 ng/L
4,68 ng/L 20 ng/L
22,00 ng/L 300 ng/L
46,40 ng/L 200 ng/L
FR
Exigences
NSF de
réduction
>99.95%
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA